Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:3 Issue:11 Number:6 ISSN#:2564-2537
RCT
ACE Report #7288
Ace Report Cover General Orthopaedics

OTA 2014: Negative-pressure wound therapy not favourable to gauze dressing for ORIF


How to Cite

OrthoEvidence. OTA 2014: Negative-pressure wound therapy not favourable to gauze dressing for ORIF. ACE Report. 2014;3(11):6. Available from: https://myorthoevidence.com/AceReport/Report/7288

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Role of Acute Negative-Pressure Wound Therapy Over Primarily Closed Surgical Incisions in Hip, Pelvis, and Acetabular Fracture Surgery: A Prospective Randomized Trial

Contributing Authors: BD Crist MS Khazzam GJ Della Rocca YM Murtha JP Stannard

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

151 patients who underwent open reduction and internal fixation (ORIF) for a hip, pelvis, or acetabular fracture were randomly assigned to receive negative-pressure wound therapy (NPWT) or standard gauze dressing over the closed incisions. Postoperative surgical wound drainage, risk of infections, and hospital duration were assessed. Findings revealed that, contrary to previously published literat...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.